In connection with the State of the Union announcement of the president's "Precision Medicine Initiative," Dean Jameson recently announced that Dr. David Roth, Acting Director of the Center for Personalized Diagnostics, is working closely with a group of other senior leaders to continue Penn's precision medicine momentum, given that it is one of the key pillars of the Penn Medicine Strategic Plan. Dr. Roth will serve the physician lead for Penn's Precision Medicine Initiative. Other efforts at Penn include the new Institute for Biomedical Informatics to be led by Dr. Jason Moore, the new Biobank directed by Drs. Dan Rader and Michael Feldman, and a redirected focus of the Department of Systems Pharmacology and Translational Therapeutics. 
To find out more, visit the Penn Precision Medicine intranet website (login required).